Non-Invasive Reduction of Abdominal Fat

Clinical Trial Description

The primary objective of the study is to achieve a discernable change to the contour of the abdominal area treated with the JUNO applicator that is consistent with that documented during a clinical study of a previous applicator used to treat lovehandles. ;

Study Design

Related Conditions & MeSH terms

Fat Reduction

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05256771` - Electrical Muscle Stimulation With 1064 nm Diode Laser and RF/PEMF for Non-invasive Body Contouring and Fat Reduction.	N/A
Completed	`NCT03647748` - Effects of Green Light Therapy on Body Contouring and Cellulite	N/A
Completed	`NCT03241563` - Subcutaneous Sodium Deoxycholate Injections With or Without Triamcinolone for Reduction of Submental Fat	Phase 4

See also

Status

Clinical Trial

Phase

Active, not recruiting

NCT05256771 - Electrical Muscle Stimulation With 1064 nm Diode Laser and RF/PEMF for Non-invasive Body Contouring and Fat Reduction.

N/A

Completed

NCT03647748 - Effects of Green Light Therapy on Body Contouring and Cellulite

N/A

Completed

NCT03241563 - Subcutaneous Sodium Deoxycholate Injections With or Without Triamcinolone for Reduction of Submental Fat

Phase 4

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01101997
Study type	Interventional
Source	Zeltiq Aesthetics
Contact
Status	Completed
Phase	N/A
Start date	March 30, 2010
Completion date	December 8, 2010

Non-Invasive Reduction of Abdominal Fat — JUNO

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms